目次

1. Report Overview
1.1. Global Cancer Biologics Therapy Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report
1.5. Who Is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation & Forecasting Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. Associated Visiongain Reports
1.9. About Visiongain

2. Introduction to the Cancer Biologics Therapy Market
2.1. Cancer Biologics Therapy Market Definition
2.2. Treatments used in Cancer Biologics Therapy Industry
2.2.1. Chemotherapy
2.2.2. Targeted Therapy
2.2.2.1. Monoclonal Antibodies
2.2.2.2. Small-Molecule Drugs
2.2.3. Immunotherapy
2.2.4. Hormonal Therapy
2.3. Cancer Biologics Therapy Industry by Indication
2.3.1. Breast Cancer
2.3.2. Cervical Cancer
2.3.3. Colon and Rectal Cancer
2.3.4. Gastric Cancer
2.3.5. Lung Cancer
2.3.6. Ovarian Cancer
2.3.7. Renal Cell Cancer
2.3.8. Melanoma

3. Cancer Biologics Therapy Market Overview
3.1. Global Oncology Spending Market Size, Market Analysis and Forecast, 2016-2031
3.2. Global and Regional Cancer Biologics Therapy Market, 2016-2031
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Rising Cancer Prevalence Worldwide
3.3.1.2. Increasing Ageing Population in Developed as well as Developing Economies
3.3.2. Market Restraints/Challenges
3.3.2.1. Shortage of Skilled Workforce in the Biopharmaceutical Industry
3.3.2.2. High Cost Associated with Biopharmaceutical Drug Manufacturing
3.3.3. Opportunities
3.3.3.1. Increasing R&D Spending of Biopharmaceutical Companies
3.3.3.2. Future Perspective in Oncology Industry
3.4. Cancer Biologics Therapy Market: SWOT Analysis
3.5. Cancer Biologics Therapy Market: Porter’s Five Forces Model
3.5.1. Bargaining Power of Buyers
3.5.2. Bargaining Power of Suppliers
3.5.3. Threats of New Entrants
3.5.4. Threats of Substitutes
3.5.5. Competitive Rivalry
3.6. European Oncology Market Trends
3.7. Disease Prevalence and Incidence in Europe
3.7.1. Germany Cancer Incidence and Mortality
3.7.2. UK Cancer Incidence and Mortality
3.7.3. France Cancer Incidence and Mortality
3.7.4. Italy Cancer Incidence and Mortality
3.7.5. Spain Cancer Incidence and Mortality
3.7.6. Portugal Cancer Incidence and Mortality
3.7.7. Poland Cancer Incidence and Mortality
3.7.8. Hungary Cancer Incidence and Mortality
3.7.9. Czech Republic Cancer Incidence and Mortality
3.7.10. Slovakia Cancer Incidence and Mortality
3.7.11. Slovenia Cancer Incidence and Mortality
3.7.12. Romania Cancer Incidence and Mortality
3.7.13. Bulgaria Cancer Incidence and Mortality
3.7.14. Croatia Cancer Incidence and Mortality
3.7.15. Serbia Cancer Incidence and Mortality
3.7.16. Estonia Cancer Incidence and Mortality
3.7.17. Latvia Cancer Incidence and Mortality
3.7.18. Lithuania Cancer Incidence and Mortality
3.8. Prescription Distribution of Bevacizumab and Trastuzumab
3.8.1. Prescription Distribution of Bevacizumab
3.8.1.1. Metastatic Colorectal Cancer
3.8.1.2. First-Line Non-Squamous Non-Small Cell Lung Cancer
3.8.1.3. Recurrent Glioblastoma
3.8.1.4. Metastatic Renal Cell Carcinoma
3.8.1.5. Persistent, Recurrent, Or Metastatic Cervical Cancer
3.8.1.6. Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
3.8.1.7. Hepatocellular Carcinoma
3.8.2. Prescription Distribution of Trastuzumab
3.8.2.1. Adjuvant Breast Cancer
3.8.2.2. Metastatic Breast Cancer
3.8.2.3. Metastatic Gastric Cancer
3.9. EMA Approval, Loss of Exclusivity and Introduction of Biosimilars Impact Analysis
3.10. Therapeutic Schemes of Bevacizumab and Trastuzumab
3.11. Patient drop-out rate
3.12. Oncologist Perceptions on Biosimilars
3.13. Barriers to Biologic Treatments and Expected Impact of Cheaper Options on the Market
3.14. Biosimilars and R&D Biologics in Development
3.14.1. Current Bevacizumab Biosimilars
3.14.2. Current Trastuzumab Biosimilars
3.14.3. Melanoma Indications

4. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Treatment Type
4.1. Chemotherapy Market Size
4.1.1. Side Effects of Chemotherapy
4.1.2. Cancer Biologics Therapy Market Outlook for Chemotherapy: Recovery Scenarios (V, U, L, W)
4.2. Targeted Therapy Market Size
4.2.1. Examples of Targeted Therapies
4.2.2. Targeted Therapies Approved for Specific Types of Cancer
4.2.3. Cancer Biologics Therapy Market Outlook for Targeted Therapy: Recovery Scenarios (V, U, L, W)
4.2.4. Tyrosine kinase inhibitors (small molecules) / mTOR, BRAF, etc. receptor targeted agents
4.2.5. Monoclonal antibodies / mAbs (VEGF, HER, DP1, etc. receptor targeted agents)
4.2.6. Antibody-drug conjugates - with mAbs or with a small molecule
4.3. Immunotherapy Market Size
4.3.1. What Does Immunotherapy Treat?
4.3.2. Types of Immunotherapy
4.3.3. Cancer Biologics Therapy Market Outlook for Immunotherapy: Recovery Scenarios (V, U, L, W)
4.4. Hormonal Therapy Market Size
4.4.1. Hormone Therapy for Breast Cancer
4.4.2. Hormone Therapy Drugs for Breast Cancer
4.4.3. Breast Cancer and Tamoxifen
4.4.4. Cancer Biologics Therapy Market Outlook for Hormonal Therapy: Recovery Scenarios (V, U, L, W)
4.5. Other Treatments Market Size
4.5.1. Are there Vaccines that Prevent Cancer?
4.5.2. Cancer Biologics Therapy Market Outlook for Other Treatments: Recovery Scenarios (V, U, L, W)

5. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Indication
5.1. Breast Cancer Market Size
5.1.1. Node Preservation Reduces Lymphedema Cases
5.1.2. Genomic Testing Minimizes Chemotherapy Exposure
5.1.3. Oral Option for Targeted Therapy
5.1.4. Breast Cancer Statistics, 2020
5.1.5. Cancer Biologics Therapy Market Outlook for Breast Cancer: Recovery Scenarios (V, U, L, W)
5.2. Cervical Cancer Market Size
5.2.1. Cancer Biologics Therapy Market Outlook for Cervical Cancer: Recovery Scenarios (V, U, L, W)
5.3. Colon and Rectal Cancer Market Size
5.3.1. Drugs Approved for Colon Cancer
5.3.2. Drugs Combinations Used in Colon Cancer
5.3.3. Drugs Approved for Rectal Cancer
5.3.4. Drugs Combinations Used in Rectal Cancer
5.3.5. Cancer Biologics Therapy Market Outlook for Colon and Rectal Cancer: Recovery Scenarios (V, U, L, W)
5.4. Gastric Cancer Market Size
5.4.1. Drugs Approved for Gastric Cancer
5.4.2. Drugs Combinations Used in Gastric Cancer
5.4.3. Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
5.4.4. Cancer Biologics Therapy Market Outlook for Gastric Cancer: Recovery Scenarios (V, U, L, W)
5.5. Lung Cancer Market Size
5.5.1. Drugs Approved for Non-Small Cell Lung Cancer
5.5.2. Drug Combinations Used to Treat Non-Small Cell Lung Cancer
5.5.3. Drugs Approved for Small Cell Lung Cancer
5.5.4. Cancer Biologics Therapy Market Outlook for Lung Cancer: Recovery Scenarios (V, U, L, W)
5.6. Ovarian Cancer Market Size
5.6.1. Available Treatments for Ovarian Cancer
5.6.2. What New Treatment Options are Under Development?
5.6.3. Cancer Biologics Therapy Market Outlook for Ovarian Cancer: Recovery Scenarios (V, U, L, W)
5.7. Renal Cell Cancer Market Size
5.7.1. Cancer Biologics Therapy Market Outlook for Renal Cell Cancer: Recovery Scenarios (V, U, L, W)
5.8. Melanoma Market Size
5.8.1. Drugs Approved for Melanoma
5.8.2. Cancer Biologics Therapy Market Outlook for Melanoma: Recovery Scenarios (V, U, L, W)
5.9. Other Indications Market Size
5.9.1. Cancer Biologics Therapy Market Outlook for Other Indications: Recovery Scenarios (V, U, L, W)

6. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Biologic Drugs
6.1. Bevacizumab Market Size
6.1.1. Bevacizumab Similar Biologic Launched in India
6.1.2. Cancer Biologics Therapy Market Outlook for Bevacizumab: Recovery Scenarios (V, U, L, W)
6.2. Trastuzumab Market Size
6.2.1. Cancer Biologics Therapy Market Outlook for Trastuzumab: Recovery Scenarios (V, U, L, W)
6.3. Trastuzumab emtansine Market Size
6.3.1. Cancer Biologics Therapy Market Outlook for Trastuzumab emtansine: Recovery Scenarios (V, U, L, W)
6.4. Pertuzumab Market Size
6.4.1. FDA Accepted Roche’s Biologics License Application
6.4.2. Cancer Biologics Therapy Market Outlook for Pertuzumab: Recovery Scenarios (V, U, L, W)
6.5. Rituximab Market Size
6.5.1. Cancer Biologics Therapy Market Outlook for Rituximab: Recovery Scenarios (V, U, L, W)
6.6. Cetuximab Market Size
6.6.1. Cancer Biologics Therapy Market Outlook for Cetuximab: Recovery Scenarios (V, U, L, W)
6.7. Panitumumab Market Size
6.7.1. Cancer Biologics Therapy Market Outlook for Panitumumab: Recovery Scenarios (V, U, L, W)
6.8. Ramucirumab Market Size
6.8.1. Cancer Biologics Therapy Market Outlook for Ramucirumab: Recovery Scenarios (V, U, L, W)
6.9. Necitumumab Market Size
6.9.1. Role of Necitumumab in the Treatment of Non-Small Cell Lung Cancer (NSCLC)?
6.9.2. Cancer Biologics Therapy Market Outlook for Necitumumab: Recovery Scenarios (V, U, L, W)
6.10. Pembrolizumab Market Size
6.10.1. What Pembrolizumab Is Used For:
6.10.2. Cancer Biologics Therapy Market Outlook for Pembrolizumab: Recovery Scenarios (V, U, L, W)
6.11. Atezolizumab Market Size
6.11.1. Atezolizumab Drug Used in below Indications
6.11.2. Cancer Biologics Therapy Market Outlook for Atezolizumab: Recovery Scenarios (V, U, L, W)
6.12. Durvalumab Market Size
6.12.1. FDA Approved Durvalumab for Extensive-Stage Small Cell Lung Cancer
6.12.2. Cancer Biologics Therapy Market Outlook for Durvalumab: Recovery Scenarios (V, U, L, W)
6.13. Nivolumab Market Size
6.13.1. FDA to Review Additional GI Cancer Indications for Nivolumab
6.13.2. Cancer Biologics Therapy Market Outlook for Nivolumab: Recovery Scenarios (V, U, L, W)
6.14. Ipilimumab Market Size
6.14.1. Cancer Biologics Therapy Market Outlook for Ipilimumab: Recovery Scenarios (V, U, L, W)

7. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Product
7.1. Monoclonal Antibodies Market Size
7.1.1. Cancer Biologics Therapy Market Outlook for Monoclonal Antibodies: Recovery Scenarios (V, U, L, W)
7.2. Cytokines Market Size
7.2.1. Cancer Biologics Therapy Market Outlook for Cytokines: Recovery Scenarios (V, U, L, W)
7.3. Cancer Growth Blockers Market Size
7.3.1. Types of Cancer Growth Blockers
7.3.2. Possible Side Effects of Cancer Growth Blockers
7.3.3. Cancer Biologics Therapy Market Outlook for Cancer Growth Blockers: Recovery Scenarios (V, U, L, W)
7.4. Vaccines Market Size
7.4.1. Cancer Biologics Therapy Market Outlook for Vaccines: Recovery Scenarios (V, U, L, W)
7.5. Blood Cell Growth Factors Market Size
7.5.1. Cancer Biologics Therapy Market Outlook for Blood Cell Growth Factors: Recovery Scenarios (V, U, L, W)
7.6. Others Market Size
7.6.1. Cancer Biologics Therapy Market Outlook for Others: Recovery Scenarios (V, U, L, W)

8. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by End User
8.1. Hospitals Market Size
8.1.1. Cancer Biologics Therapy Market Outlook for Hospitals: Recovery Scenarios (V, U, L, W)
8.2. Specialty Clinics Market Size
8.2.1. Cancer Biologics Therapy Market Outlook for Specialty Clinics: Recovery Scenarios (V, U, L, W)
8.3. Cancer and Radiation Therapy Centers Market Size
8.3.1. How is the Cancer Research Institute Involved in the Development of Immunotherapy?
8.3.2. Cancer Biologics Therapy Market Outlook for Cancer and Radiation Therapy Centers: Recovery Scenarios (V, U, L, W)

9. North America Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031
9.1. North America Cancer Biologics Therapy Market Size
9.1.1. North America Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
9.2. U.S. Cancer Biologics Therapy Market Size
9.3. Canada Cancer Biologics Therapy Market Size

10. Europe Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031
10.1. Europe Cancer Biologics Therapy Market Size
10.1.1. Europe Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
10.2. UK Cancer Biologics Therapy Market Size
10.3. Germany Cancer Biologics Therapy Market Size
10.4. France Cancer Biologics Therapy Market Size
10.5. Italy Cancer Biologics Therapy Market Size
10.6. Spain Cancer Biologics Therapy Market Size
10.7. Portugal Cancer Biologics Therapy Market Size
10.8. Poland Cancer Biologics Therapy Market Size
10.9. Hungary Cancer Biologics Therapy Market Size
10.10. Czech Republic Cancer Biologics Therapy Market Size
10.11. Slovakia Cancer Biologics Therapy Market Size
10.12. Slovenia Cancer Biologics Therapy Market Size
10.13. Romania Cancer Biologics Therapy Market Size
10.14. Bulgaria Cancer Biologics Therapy Market Size
10.15. Croatia Cancer Biologics Therapy Market Size
10.16. Baltic States Cancer Biologics Therapy Market Size
10.17. Serbia Cancer Biologics Therapy Market Size
10.18. Rest of Europe Cancer Biologics Therapy Market Size

11. Asia Pacific Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031
11.1. Asia Pacific Cancer Biologics Therapy Market Size
11.1.1. Asia Pacific Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
11.2. China Cancer Biologics Therapy Market Size
11.3. India Cancer Biologics Therapy Market Size
11.4. Japan Cancer Biologics Therapy Market Size
11.5. South Korea Cancer Biologics Therapy Market Size
11.6. Australia Cancer Biologics Therapy Market Size
11.7. Rest of Asia Pacific Cancer Biologics Therapy Market Size

12. Latin America Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031
12.1. Latin America Cancer Biologics Therapy Market Size
12.1.1. Latin America Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
12.2. Brazil Cancer Biologics Therapy Market Size
12.3. Mexico Cancer Biologics Therapy Market Size
12.4. Argentina Cancer Biologics Therapy Market Size
12.5. Rest of Latin America Cancer Biologics Therapy Market Size

13. Middle East & Africa Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031
13.1. Middle East & Africa Cancer Biologics Therapy Market Size
13.1.1. Middle East & Africa Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
13.2. South Africa Cancer Biologics Therapy Market Size
13.3. GCC Cancer Biologics Therapy Market Size
13.4. Rest of Middle East & Africa Cancer Biologics Therapy Market Size

14. Company Profiles
14.1. AbbVie Inc.
14.1.1. AbbVie Inc. Snapshot
14.1.2. Company Overview
14.1.3. Product Offerings
14.1.4. AbbVie Inc.: Recent Initiatives, 2017 - 2020
14.1.5. Financial Performance (2015 - 2019)
14.1.5.1. Net Revenue (2015 - 2019)
14.1.5.2. Gross Profit (2015 - 2019)
14.1.5.3. Geographical Revenue, 2019
14.2. F.Hoffman La Roche
14.2.1. F.Hoffman La Roche Snapshot
14.2.2. Company Overview
14.2.3. Product Offerings
14.2.4. F.Hoffman La Roche: Recent Initiatives, 2017 - 2020
14.2.5. Financial Performance (2015 - 2019)
14.2.5.1. Net Revenue (2015 - 2019)
14.2.5.2. Gross Profit (2015 - 2019)
14.2.5.3. Geographical Revenue, 2019
14.3. GlaxoSmithKline
14.3.1. GlaxoSmithKline Snapshot
14.3.2. Company Overview
14.3.3. Product Offerings
14.3.4. GlaxoSmithKline: Recent Initiatives, 2017 - 2020
14.3.5. Financial Performance (2015 - 2019)
14.3.5.1. Net Revenue (2015 - 2019)
14.3.5.2. Gross Profit (2015 - 2019)
14.3.5.3. Geographical Revenue, 2019
14.4. Eli Lilly and Company
14.4.1. Eli Lilly and Company Snapshot
14.4.2. Company Overview
14.4.3. Product Offerings
14.4.4. Eli Lilly and Company: Recent Initiatives, 2017 - 2020
14.4.5. Financial Performance (2015 - 2019)
14.4.5.1. Net Revenue (2015 - 2019)
14.4.5.2. Gross Profit (2015 - 2019)
14.4.5.3. Geographical Revenue, 2019
14.5. Amgen
14.5.1. Amgen Snapshot
14.5.2. Company Overview
14.5.3. Product Offerings
14.5.4. Amgen: Recent Initiatives, 2017 - 2020
14.5.5. Financial Performance (2015 - 2019)
14.5.5.1. Net Revenue (2015 - 2019)
14.5.5.2. Gross Profit (2015 - 2019)
14.5.5.3. Geographical Revenue, 2019
14.6. Johnson & Johnson
14.6.1. Johnson & Johnson Snapshot
14.6.2. Company Overview
14.6.3. Product Offerings
14.6.4. Johnson & Johnson: Recent Initiatives, 2017 - 2020
14.6.5. Financial Performance (2015 - 2019)
14.6.5.1. Net Revenue (2015 - 2019)
14.6.5.2. Gross Profit (2015 - 2019)
14.6.5.3. Geographical Revenue, 2019
14.7. Merck & Co.
14.7.1. Merck & Co. Snapshot
14.7.2. Company Overview
14.7.3. Product Offerings
14.7.4. Merck & Co.: Recent Initiatives, 2017 - 2020
14.7.5. Financial Performance (2015 - 2019)
14.7.5.1. Net Revenue (2015 - 2019)
14.7.5.2. Gross Profit (2015 - 2019)
14.7.5.3. Geographical Revenue, 2019
14.8. Pfizer
14.8.1. Pfizer Snapshot
14.8.2. Company Overview
14.8.3. Product Offerings
14.8.4. Pfizer: Recent Initiatives, 2017 - 2020
14.8.5. Financial Performance (2015 - 2019)
14.8.5.1. Net Revenue (2015 - 2019)
14.8.5.2. Gross Profit (2015 - 2019)
14.8.5.3. Geographical Revenue, 2019
14.9. Agilent Technologies, Inc.
14.9.1. Company Overview
14.9.2. Product Benchmarking
14.9.3. Agilent Technologies, Inc.: Recent Initiatives
14.9.4. Financial Performance (2016 - 2019)
14.10. Bio-Rad Laboratories
14.10.1. Company Overview
14.10.2. Product Benchmarking
14.10.3. Bio-Rad Laboratories: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
14.10.4. Financials
14.11. GE Healthcare
14.11.1. Company Overview
14.11.2. Product Benchmarking
14.11.3. GE Healthcare: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
14.11.4. Financials
14.12. Illumina
14.12.1. Company Overview
14.12.2. Product Benchmarking
14.12.3. Illumina: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
14.12.4. Financials
14.13. Qiagen N.V.
14.13.1. Company Overview
14.13.2. Product Benchmarking
14.13.3. Qiagen N.V.: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
14.13.4. Financials
14.14. Biocept
14.14.1. Biocept Snapshot
14.14.2. Company Overview
14.14.3. Product Offerings
14.14.4. Biocept: Recent Initiatives, 2017 - 2020
14.14.5. Financial Performance (2015 - 2019)
14.15. Guardant Health
14.15.1. Guardant Health Snapshot
14.15.2. Company Overview
14.15.3. Product Offerings
14.15.4. Guardant Health: Recent Initiatives, 2017 - 2020
14.15.5. Financial Performance (2015 - 2019)

15. Conclusion
15.1. Concluding Remarks
15.2. Recommendations

List of Figures
Figure 1 Cancer Biologics Therapy: Market Segmentation and Scope
Figure 2 Global Oncology Spending Market Value Forecast, 2016 - 2031 (USD Billion)
Figure 3 Global Oncology Spending Market Share by Region, 2020 (%)
Figure 4 Cancer Biologics Therapy Market Share by Region, 2021, 2026, 2031 (%)
Figure 5 Worldwide Cancer Death by Age, 2019 (%)
Figure 6 Share of population with Cancer, 2019 (%)
Figure 7 Ageing Population Estimates 2010 - 2050
Figure 8 Research & Development Spending as a Percent of Revenue by Biopharmaceutical Companies, 2019 (%)
Figure 9 Cancer Biologics Therapy Industry: Porter’s Five Forces Model
Figure 10 Germany: Estimated Incidence by Cancer, 2020 (%)
Figure 11 Germany: Estimated Mortality by Cancer, 2020 (%)
Figure 12 UK: Estimated Incidence by Cancer, 2020 (%)
Figure 13 UK: Estimated Mortality by Cancer, 2020 (%)
Figure 14 France: Estimated Incidence by Cancer, 2020 (%)
Figure 15 France: Estimated Mortality by Cancer, 2020 (%)
Figure 16 Italy: Estimated Incidence by Cancer, 2020 (%)
Figure 17 Italy: Estimated Mortality by Cancer, 2020 (%)
Figure 18 Spain: Estimated Incidence by Cancer, 2020 (%)
Figure 19 Spain: Estimated Mortality by Cancer, 2020 (%)
Figure 20 Portugal: Estimated Incidence by Cancer, 2020 (%)
Figure 21 Portugal: Estimated Mortality by Cancer, 2020 (%)
Figure 22 Poland: Estimated Incidence by Cancer, 2020 (%)
Figure 23 Poland: Estimated Mortality by Cancer, 2020 (%)
Figure 24 Hungary: Estimated Incidence by Cancer, 2020 (%)
Figure 25 Hungary: Estimated Mortality by Cancer, 2020 (%)
Figure 26 Czech Republic: Estimated Incidence by Cancer, 2020 (%)
Figure 27 Czech Republic: Estimated Mortality by Cancer, 2020 (%)
Figure 28 Slovakia: Estimated Incidence by Cancer, 2020 (%)
Figure 29 Slovakia: Estimated Mortality by Cancer, 2020 (%)
Figure 30 Slovenia: Estimated Incidence by Cancer, 2020 (%)
Figure 31 Slovenia: Estimated Mortality by Cancer, 2020 (%)
Figure 32 Romania: Estimated Incidence by Cancer, 2020 (%)
Figure 33 Romania: Estimated Mortality by Cancer, 2020 (%)
Figure 34 Bulgaria: Estimated Incidence by Cancer, 2020 (%)
Figure 35 Bulgaria: Estimated Mortality by Cancer, 2020 (%)
Figure 36 Croatia: Estimated Incidence by Cancer, 2020 (%)
Figure 37 Croatia: Estimated Mortality by Cancer, 2020 (%)
Figure 38 Serbia: Estimated Incidence by Cancer, 2020 (%)
Figure 39 Serbia: Estimated Mortality by Cancer, 2020 (%)
Figure 40 Estonia: Estimated Incidence by Cancer, 2020 (%)
Figure 41 Estonia: Estimated Mortality by Cancer, 2020 (%)
Figure 42 Latvia: Estimated Incidence by Cancer, 2020 (%)
Figure 43 Latvia: Estimated Mortality by Cancer, 2020 (%)
Figure 44 Lithuania: Estimated Incidence by Cancer, 2020 (%)
Figure 45 Lithuania: Estimated Mortality by Cancer, 2020 (%)
Figure 46 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 47 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 48 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 49 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 50 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 51 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 52 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 53 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 54 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 55 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 56 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 57 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 58 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 59 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 60 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 61 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 62 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 63 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 64 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 65 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 66 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 67 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 68 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 69 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 70 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 71 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 72 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 73 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 74 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 75 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 76 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 77 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 78 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 79 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 80 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 81 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 82 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 83 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 84 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 85 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 86 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 87 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 88 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 89 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 90 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 91 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 92 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 93 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 94 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 95 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 96 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 97 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 98 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 99 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 100 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 101 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 102 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 103 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 104 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 105 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 106 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 107 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 108 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 109 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 110 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 111 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 112 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 113 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 114 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 115 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 116 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 117 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 118 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 119 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 120 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 121 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 122 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 123 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 124 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 125 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 126 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 127 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 128 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 129 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 130 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 131 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 132 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 133 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 134 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 135 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 136 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 137 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 138 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 139 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 140 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 141 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 142 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 143 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 144 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 145 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 146 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 147 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 148 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 149 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 150 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 151 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 152 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 153 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 154 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 155 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 156 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 157 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 158 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 159 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 160 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 161 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 162 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 163 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 164 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 165 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 166 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 167 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 168 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 169 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 170 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 171 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 172 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 173 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 174 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 175 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 176 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 177 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 178 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 179 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 180 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 181 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 182 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 183 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 184 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 185 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 186 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 187 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 188 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 189 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 190 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 191 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 192 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 193 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 194 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 195 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 196 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 197 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 198 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 199 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 200 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 201 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 202 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 203 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 204 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 205 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 206 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 207 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 208 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 209 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 210 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 211 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 212 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 213 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 214 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 215 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 216 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 217 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 218 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 219 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 220 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 221 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 222 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 223 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 224 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 225 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 226 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 227 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 228 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 229 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 230 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 231 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 232 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 233 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 234 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 235 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 236 U.S. Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 237 Canada Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 238 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 239 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 240 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 241 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 242 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 243 UK Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 244 Germany Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 245 France Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 246 Italy Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 247 Spain Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 248 Portugal Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 249 Poland Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 250 Hungary Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 251 Czech Republic Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 252 Slovakia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 253 Slovenia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 254 Romania Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 255 Bulgaria Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 256 Croatia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 257 Baltic States Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 258 Serbia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 259 Serbia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 260 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 261 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 262 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 263 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 264 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 265 China Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 266 India Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 267 Japan Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 268 South Korea Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 269 Australia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 270 Rest of Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 271 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 272 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 273 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 274 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 275 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 276 Brazil Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 277 Mexico Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 278 Argentina Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 279 Rest of Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 280 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 281 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
Figure 282 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
Figure 283 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
Figure 284 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
Figure 285 South Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 286 GCC Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 287 Rest of Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
Figure 288 AbbVie Inc.: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 289 AbbVie Inc.: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 290 AbbVie Inc.: Geographical Revenue, 2019 (USD Million)
Figure 291 F.Hoffman La Roche: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 292 F.Hoffman La Roche: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 293 F.Hoffman La Roche: Geographical Revenue, 2019 (USD Million)
Figure 294 GlaxoSmithKline: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 295 GlaxoSmithKline: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 296 GlaxoSmithKline: Geographical Revenue, 2019 (USD Million)
Figure 297 Eli Lilly and Company: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 298 Eli Lilly and Company: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 299 Eli Lilly and Company: Geographical Revenue, 2019 (USD Million)
Figure 300 Amgen: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 301 Amgen: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 302 Amgen: Geographical Revenue, 2019 (USD Million)
Figure 303 Johnson & Johnson: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 304 Johnson & Johnson: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 305 Johnson & Johnson: Geographical Revenue, 2019 (USD Million)
Figure 306 Merck & Co.: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 307 Merck & Co.: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 308 Merck & Co.: Geographical Revenue, 2019 (USD Million)
Figure 309 Pfizer: Net Revenue 2015 - 2019, (USD Million, AGR %)
Figure 310 Pfizer: Gross Profit 2015 - 2019, (USD Million, AGR %)
Figure 311 Pfizer: Geographical Revenue, 2019 (USD Million)
Figure 312 Agilent Technologies, Inc.: Financials 2016 - 2019, (USD Million, AGR %)
Figure 313 Agilent Technologies, Inc.: Business Segment, 2019 (%)
Figure 314 Agilent Technologies, Inc.: Sales by Type, 2019 (%)
Figure 315 Agilent Technologies, Inc.: Market by Region, 2019 (%)
Figure 316 Bio-Rad Laboratories: Financials 2016 - 2019, (USD Million, AGR %)
Figure 317 Bio-Rad Laboratories: Business Segment, 2019 (%)
Figure 318 Bio-Rad Laboratories: Market by Region, 2019 (%)
Figure 319 GE Healthcare: Financials 2016 - 2019, (USD Million, AGR %)
Figure 320 GE Healthcare: Business Segment, 2019 (%)
Figure 321 GE Healthcare: Type of Sales, 2019 (%)
Figure 322 GE Healthcare: Market by Region, 2019 (%)
Figure 323 Illumina: Financials 2016 - 2019, (USD Million, AGR %)
Figure 324 Illumina: Business Segment, 2019 (%)
Figure 325 Illumina: Market by Region, 2019 (%)
Figure 326 Qiagen N.V.: Financials 2016 - 2019, (USD Million, AGR %)
Figure 327 Qiagen N.V.: Business Segment, 2019 (%)
Figure 328 Qiagen N.V.: Market by Region, 2019 (%)
Figure 329 Biocept: Net Revenue 2015 - 2019, (USD Thousand, AGR %)
Figure 330 Guardant Health: Net Revenue 2015 - 2019, (USD Million, AGR %)

List of Tables
Table 1 Cancer Biologics Therapy Market, 2016-2020 (USD Billion)
Table 2 Cancer Biologics Therapy Market, 2021-2031 (USD Billion)
Table 3 Cancer Biologics Therapy Market: SWOT Analysis
Table 4 EMA Approved Biosimilars in Oncology
Table 5 FDA Approved Biosimilars in Oncology
Table 6 Current Bevacizumab Biosimilars
Table 7 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 8 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 9 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 10 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 11 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 12 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 13 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 14 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 15 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 16 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 17 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 18 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 19 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 20 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 21 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 22 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 23 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 24 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 25 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 26 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 27 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 28 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 29 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 30 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 31 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 32 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 33 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 34 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 35 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 36 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 37 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 38 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 39 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 40 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 41 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 42 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 43 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 44 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 45 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 46 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 47 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
Table 48 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
Table 49 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
Table 50 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
Table 51 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
Table 52 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (US